Prognostic significance of mild aortic regurgitation in predicting mortality after transcatheter aortic valve replacement  Brandon M. Jones, MD, E. Murat.

Slides:



Advertisements
Similar presentations
Table 1 : Baseline Characteristics
Advertisements

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
A cherry blossom moment in the history of heart valve replacement
Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 
Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Emergency use of cardiopulmonary bypass in complicated transcatheter aortic valve replacement: Importance of a heart team approach  Eric E. Roselli, MD,
A comprehensive review of the PARTNER trial
Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement  Samir R. Kapadia,
Relative amplitude index: A new tool for hemodynamic evaluation of periprosthetic regurgitation after transcatheter valve implantation  Anneliese Heinz,
Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years  Jian Ye, MD, FRCSC, John G. Webb, MD,
Open transcatheter tricuspid balloon expandable valve-in-valve implantation for failed bioprosthesis  Gino Gerosa, MD, Augusto D'Onofrio, MD, Chiara Tessari,
Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis  Akin Cam, MD, Sachin S. Goel, MD, Shikhar Agarwal, MD, MPH,
Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.
Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement  Charles R. Bridges, MD,
Transapical transcatheter aortic valve implantation and off-pump left internal thoracic artery–left anterior descending anastomosis: Back to the future? 
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
B. Zane Atkins, MD, Zubair A. Hashmi, MD, Asvin M. Ganapathi, MD, J
Marc R. Moon, MD  The Journal of Thoracic and Cardiovascular Surgery 
Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.
Hassane Abdallah, MD, Alaae Boutayeb, MD, Gebrine El Khoury, PhD 
Charles C. Sticco, DO, Leonard O. Barrett, MD 
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Starr–Edwards aortic valve: Forty-four years old and still working!
Aortic root morphology in patients undergoing percutaneous aortic valve replacement: Evidence of aortic root remodeling  Mateen Akhtar, MD, E. Murat Tuzcu,
Myriad manifestations of myxoma
Low Incidence of Paravalvular Leakage With the Balloon-Expandable Sapien 3 Transcatheter Heart Valve  Daniel Wendt, MD, Fadi Al-Rashid, MD, Philipp Kahlert,
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Accuracy of transesophageal echocardiography in the identification of postoperative intramural ventricular septal defects  Jyoti K. Patel, MD, Andrew.
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines  Javier G. Castillo, MD, Anelechi.
Transcatheter valve-in-valve implantation for the treatment of stentless aortic valve dysfunction  Josep Rodés-Cabau, MD, FESC, Eric Dumont, MD, Daniel.
Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis  Adil H. Al Kindi,
Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients  Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Lukas.
Transcatheter aortic valve replacement in intermediate-risk patients
Michele Gallo, MD, Gino Gerosa, MD 
Joshua M. Rosenblum, MD, PhD, Bradley G. Leshnower, MD, Rena C
The aortic valve–sparing operation
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Torsten Doenst, MD, PhD, Markus Richter, MD 
Aborted sternotomy due to unexpected porcelain aorta: Does transcatheter aortic valve replacement offer an alternative choice?  Jahanzaib Idrees, MD,
Stent and leaflet stresses in a 26-mm first-generation balloon-expandable transcatheter aortic valve  Yue Xuan, PhD, Kapil Krishnan, PhD, Jian Ye, MD,
Compassionate aortic valve implantation for severe aortic regurgitation  Gregory Ducrocq, MD, Dominique Himbert, MD, Ulrik Hvass, MD, Alec Vahanian, MD 
A cherry blossom moment in the history of heart valve replacement
What is a “good” result after transcatheter mitral repair
Replicating the success of mitral valve repair in the aortic valve
Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation  Aaron Martin, MD, Michael.
Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients  Alberto.
Michael Chenier, MD, MPH, Krishna K. Patel, MD, Lars G
United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex  Lars G. Svensson, MD, PhD, Todd Dewey,
Hans-Joachim Schäfers, MD 
Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend  G. Michael Deeb, MD, John Carroll, MD  The Journal.
Concomitant replacement of the ascending aorta is free—for some
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement 
Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone?  Juan A. Crestanello, MD  The Journal of.
The future of cardiac surgery training: A survival guide
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Commentary: When a choice is not an echo
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: Impact of aortic cusp calcification on postoperative aortic regurgitation 
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
“The more things change…”: The challenges ahead
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Transcatheter aortic and mitral valve implantation in bioprosthetic valves: When one correction is not enough  Adanna C. Akujuo, MD, FACS, Sophia L. Dellis,
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Three mechanisms of early failure of transcatheter aortic valves: Valve thrombosis, cusp rupture, and accelerated calcification  Matthew R. Summers, MD,
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Presentation transcript:

Prognostic significance of mild aortic regurgitation in predicting mortality after transcatheter aortic valve replacement  Brandon M. Jones, MD, E. Murat Tuzcu, MD, Amar Krishnaswamy, MD, Zoran Popovic, MD, Stephanie Mick, MD, Eric E. Roselli, MD, Sajjad Gul, MD, Jasneet Devgun, BS, Sohi Mistry, Wael A. Jaber, MD, Lars G. Svensson, MD, Samir R. Kapadia, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 152, Issue 3, Pages 783-790 (September 2016) DOI: 10.1016/j.jtcvs.2016.05.023 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Incidence and severity of AR before and after TAVR based on a clinical, echocardiographic grading scheme. TAVR, Transcatheter aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan–Meier estimated mortality at 1 year with varying degrees of AR after TAVR as judged by a clinical echocardiographic grading scheme. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Long-term Kaplan–Meier estimated survival with varying degrees of AR after TAVR as judged by a clinical echocardiographic grading scheme with number of patients at risk at each time interval. AR, Aortic regurgitation. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Long-term Kaplan–Meier survival (A) and 1-year Kaplan–Meier estimated mortality (B) based on a collapsed 3-scale grading scheme for AR after TAVR. Mild includes trivial to 1+, 1+, or 1 to 2+. Moderate includes 2+, 2 to 3+, or 3+. Severe includes 3 to 4+ and 4+. P values based on adjusted HRs comparing groups in the multivariable Cox proportional hazard model. N/A, Not available; TAVR, transcatheter aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Representative, quantitative variables used in the grading of aortic regurgitation after transcatheter aortic valve replacement based on a more granular, clinical grading scale as adapted from American Society of Echocardiography and Valve Academic Research Consortium guidelines. Note that these are not rigid rules but guidelines, and between-grade options are useful for grading cases with discordant data. AR, Aortic regurgitation; n/a, not available; LV, left ventricle. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Mortality at 1 year with varying degrees of AR after TAVR. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Video 1 Management of acute paravalvular AR after TAVR. This video shows implantation of a #23 Edwards SAPIEN (Edwards Lifesciences, Irvine, Calif) aortic valve in an 88-year-old woman with severe AS. After valve deployment, there is severe AR as seen by transesophageal echocardiogram and by near equalization of the aortic diastolic and left ventricle end-diastolic pressures. Balloon postdilation is completed, and there is only trivial residual paravalvular regurgitation as seen by transesophageal echocardiogram, hemodynamic evaluation, and root aortography. Video available at http://www.jtcvsonline.org/article/S0022-5223(16)30461-5/addons. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 783-790DOI: (10.1016/j.jtcvs.2016.05.023) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions